Related Experiment Video
Updated: Feb 17, 2026

Molecular Modulation by Lentivirus-Delivered Specific shRNAs in Endoplasmic Reticulum Stressed Neurons
Published on: April 24, 2021
Celastrol induces apoptosis in hepatocellular carcinoma cells via targeting ER-stress/UPR
1The Key Laboratory of Pathobiology, Ministry of Education, Jilin University, Changchun 130021, China.
Abstract:
Hepatocellular carcinoma (HCC) is one of the most serious and deadly diseases worldwide with limited options for effective treatment. Biomarker-based active compound targeting therapy may shed some light on novel drugs for HCC. The endoplasmic reticulum (ER) stress and unfolded protein response (UPR) play important roles in the regulation of cell fate and have become novel signaling targets for the development of anticancer drugs. Celastrol, a triterpene from traditional Chinese medicine, has been reported to possess anti-tumor effects on various cancers. We, along with several other research groups, have recently reported that UPR was induced by celastrol in several different cancers, including hepatocellular carcinoma. However, UPR status in HCC still remains unclear. The role of ER stress and autophagy in response to celastrol also has yet to be elucidated. Our results demonstrated that celastrol could cause G2/M phase rest and inhibit proliferation in HepG2 and Bel7402. Exposure to celastrol resulted in the activation of the intrinsic apoptotic pathway, via ER stress and the UPR. In murine syngeneic model studies celastrol inhibited H22 tumor growth via the induction of ER stress and apoptosis. Our study suggests that celastrol is a potential drug for HCC therapy via targeting ER-stress/UPR.
Insights
Celastrol, a compound from traditional Chinese medicine, shows promise for treating hepatocellular carcinoma (HCC). It inhibits cancer cell proliferation and tumor growth by inducing endoplasmic reticulum (ER) stress and the unfolded protein response (UPR).
Area of Science:
- Oncology
- Molecular Biology
- Pharmacology
Background:
- Hepatocellular carcinoma (HCC) presents significant global health challenges with limited therapeutic options.
- Endoplasmic reticulum (ER) stress and the unfolded protein response (UPR) are critical in cell fate regulation and emerging as targets for anticancer drug development.
- Celastrol, a natural compound, exhibits anti-tumor properties, with prior research indicating UPR induction in various cancers.
Purpose of the Study:
- To investigate the role of ER stress and UPR in hepatocellular carcinoma (HCC) response to celastrol.
- To elucidate the mechanisms by which celastrol affects HCC cell proliferation and tumor growth.
- To evaluate celastrol as a potential therapeutic agent for HCC.
Main Methods:
- Cell proliferation assays and cell cycle analysis in HepG2 and Bel7402 HCC cell lines treated with celastrol.
- Assessment of apoptosis, ER stress markers, and UPR activation following celastrol exposure.
- Evaluation of celastrol's anti-tumor efficacy in a murine syngeneic H22 tumor model.
Main Results:
- Celastrol treatment led to G2/M cell cycle arrest and inhibited proliferation in HCC cell lines.
- Celastrol induced apoptosis through the activation of the intrinsic apoptotic pathway, mediated by ER stress and UPR.
- In vivo studies demonstrated that celastrol suppressed H22 tumor growth by promoting ER stress and apoptosis.
Conclusions:
- Celastrol effectively inhibits HCC cell proliferation and tumor growth.
- The anti-cancer effects of celastrol in HCC are linked to the induction of ER stress and UPR, leading to apoptosis.
- Celastrol represents a potential therapeutic candidate for HCC, targeting the ER-stress/UPR pathway.
Related Concept Videos
The Intrinsic Apoptotic Pathway
The Unfolded Protein Response
Role of ER in the Secretory Pathway
Components of the secretory pathway
About a third of proteins synthesized in the cell are sorted via the secretory route. They shuffle between different compartments in membrane-bound vesicles until they reach their final destination. The main intracellular compartments involved...
Regulation of the Unfolded Protein Response
